BioCentury
ARTICLE | Clinical News

Tivozanib: Phase II final data

March 30, 2015 7:00 AM UTC

An analysis of patients with low serum neuropilin 1 (NRP1) levels in the open-label, international Phase II BATON-CRC trial in 265 patients with previously untreated mCRC showed that first-line treat...